博客

Delivering the resilient infrastructure essential for improving human health

首页
的见解
博客
Delivering the resilient infrastructure essential for improving human health

安吉洛贝尔纳迪

生命科学全球技术领先

The GTEN provides Wood and our clients with immediate access to the collective ingenuity of our subject matter experts.

总部位于米兰, 意大利, Angelo Bernardis is Wood’s Global Technical Leader for Life Sciences, part of our Global Technical Expert Network (GTEN). Angelo sits down with Au’Janae Roberts to share how we design, 工程师, 构造, and operate large-scale facilities that help manufacturers develop the products and vaccines needed in today’s challenging healthcare environment.

安吉洛贝尔纳迪

I recognised the challenges of the life sciences market back in 1995 when a fatal outbreak of Ebola virus spread across the Democratic Republic of Congo, 感染了300多人. As news of the viral infection led headlines worldwide, I knew there would be an increased need for sustainable infrastructure in the pharmaceutical and healthcare industry to meet expanding demands and the threats of global pandemics. 同年, I joined Wood to manage the process design department in the heart of Milan, focusing on the development of pharmaceutical facilities that manufacture quality products essential for improving human health.

人口老龄化, 医疗成本上升, 推动制造业回流, 生物技术进展, 创新的趋势, 复杂的法规, and costly infrastructure are putting mounting pressure on the global healthcare market. The issues facing the healthcare industry today have been further exacerbated by COVID-19, one of the most unprecedented global pandemic crises of our time.

历世历代, the world has tackled an endless string of outbreaks, 流行病和流行病, underscoring the growing importance of vaccine production, 口服固体剂型制造, 也很安全, innovative facilities to investigate and treat highly contagious diseases.

With the growing demand to build a more sustainable healthcare system, manufacturers are increasingly in need of innovative infrastructure delivery partners who can help them flexibly adapt production processes, operate cost-effectively and maintain the safety and efficacy of their products. 作为生命科学领域的全球技术领导者, I work with subject matter experts to develop advanced technical solutions from across all sectors of our infrastructure capability, 支撑建筑, 测试, qualification and the ongoing certification of facilities.

Wood’s expertise spans all aspects of pharmaceutical re搜索, 开发制造, 包括生物制药, 液体和固体剂型, 飞行员的植物, 研究实验室, 消费者健康产品. We are a single-source provider of cost-effective design, 工程, 建设, 操作, 以及维护解决方案. Our comprehensive capabilities help clients develop large-scale facilities that enable the discovery and development of innovative medicines and life-saving treatments for chronic conditions.

GTEN

As more manufacturers look to increase value by using emerging innovations, our experts apply advanced tools and proprietary project management technologies – such as virtual reality, digital twins and process modelling – to enhance the efficiency and performance of our designs. 在设计过程的每个阶段, 我们将可持续发展纳入蓝图, offering environmental impact assessments and sophisticated energy conservation techniques. This lays a solid foundation for developing high-quality, resilient infrastructure. To ensure the successful start-up and 操作 of facilities, 我们设计并验证它们的遵从性, providing project and design documentation tailored to suit pharmaceutical regulatory requirements. 通过这种方法, we provide cost-conscious 工程师ed solutions in one of the most highly regulated industries. This is critical since manufacturing is becoming ever more competitive and profit margins under strain.

高效的产品流程, 更高的产量, 更低的公用事业成本, and greater 操作al up-time are all essential to improving the utilisation of equipment, 减少所需的资本投资, 降低了开支. 我们提供设备和设施方面的专业知识, full CQV k现在-how and proven project execution capability to help get our clients’ products to market quickly and cost-effectively. 我们关注的是过程体系结构, 确保产品, people and material flows are optimised to deliver a well-coordinated and seamless manufacturing 操作.